{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:28:04Z","timestamp":1782890884636,"version":"3.54.5"},"reference-count":34,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Mission:Cure"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>CFTR-related metabolic syndrome (CRMS) is a novel diagnosis due to widespread use of and advances in the newborn screening (NBS) process for cystic fibrosis (CF) in the United States of America, allowing for the diagnosis of asymptomatic children with CF. Before 2015, a large Puerto Rican pediatric population was not screened for CF in the NBS test. Studies have shown that patients presenting with idiopathic recurrent or chronic pancreatitis have an increased frequency of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations. We present a retrospective chart review of 12 pediatric cases (n = 12) that were presented to an outpatient community clinic with clinical manifestations associated with CF. The pancreatic insufficiency prevalence (PIP) score was calculated on CFTR mutations. The mutations considered for the calculation of the PIP score were: F508del (c.1521_1523del), V201M (c.601G &gt; A), I507del (c.1519_1521del), and L1335P (c.4004T &gt; C). V201M mutation was classified as mild in both PIP scores, and a correlation with pancreatitis was noted. Clinical manifestations vary in cases with the V201M variant (c.601G &gt; A). One case was diagnosed with CFTR-related disorder (CRD) and recurrent pancreatitis. It is important to consider CRMS or CRD as a differential diagnosis in the pediatric population of Puerto Rico due to the implications and increased risk of pancreatitis and other CF-related complications.<\/jats:p>","DOI":"10.3390\/children10020280","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T02:52:02Z","timestamp":1675219922000},"page":"280","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CFTR-Related Metabolic Syndrome: Genetic Variants Increasing Pancreatitis Risk in the Pediatric Puerto Rican Population"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4441-6780","authenticated-orcid":false,"given":"Jes\u00fas M.","family":"Mel\u00e9ndez-Monta\u00f1ez","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Basic Science, Ponce Health Sciences University, Ponce, PR 00716, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-3517","authenticated-orcid":false,"given":"Wilfredo","family":"De Jes\u00fas-Rojas","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Basic Science, Ponce Health Sciences University, Ponce, PR 00716, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation","volume":"181S","author":"Farrell","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.jpeds.2009.09.003","article-title":"Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond","volume":"155","author":"Borowitz","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12016-008-8083-0","article-title":"Atypical Cystic Fibrosis and CFTR-Related Diseases","volume":"35","author":"Paranjape","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/humu.20232","article-title":"Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers","volume":"26","author":"Cohn","year":"2005","journal-title":"Hum. Mutat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/MOG.0000000000000764","article-title":"Demographics and risk factors for pediatric recurrent acute pancreatitis","volume":"37","author":"Gariepy","year":"2021","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcf.2012.05.001","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis","volume":"11","author":"Ooi","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"ref_7","unstructured":"(2022, July 01). US CF Foundation; J.H.U.; The Hospital for Sick Children. CFTR2 Database. Available online: https:\/\/cftr2.org\/."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1542\/peds.2004-1764","article-title":"Pancreatitis among patients with cystic fibrosis: Correlation with pancreatic status and genotype","volume":"115","author":"Weren","year":"2005","journal-title":"Pediatrics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1164\/rccm.201111-2068WS","article-title":"Future directions in early cystic fibrosis lung disease research: An NHLBI workshop report","volume":"185","author":"Ramsey","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1038\/nrdp.2015.10","article-title":"Cystic fibrosis","volume":"1","author":"Ratjen","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/112_2015_5002","article-title":"CFTR: A New Horizon in the Pathomechanism and Treatment of Pancreatitis","volume":"170","author":"Hegyi","year":"2016","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.gastro.2010.09.046","article-title":"Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis","volume":"140","author":"Ooi","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jcf.2014.01.007","article-title":"Prediction of acute pancreatitis risk based on PIP score in children with cystic fibrosis","volume":"13","author":"Terlizzi","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jmoldx.2011.05.004","article-title":"Orphan Missense Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator","volume":"13","author":"Fresquet","year":"2011","journal-title":"J. Mol. Diagn."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sepahzad, A., Morris-Rosendahl, D.J., and Davies, J.C. (2021). Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine. Genes, 12.","DOI":"10.3390\/genes12040562"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1172\/JCI35138","article-title":"Gene modifiers in cystic fibrosis","volume":"118","author":"Accurso","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s10620-019-05653-z","article-title":"Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: True Association or EPIphenomenon?","volume":"64","author":"Jawaid","year":"2019","journal-title":"Digestive Diseases and Sciences"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.4634","article-title":"Pancreatic pathophysiology in cystic fibrosis","volume":"238","author":"Meyerholz","year":"2016","journal-title":"J. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"a009746","DOI":"10.1101\/cshperspect.a009746","article-title":"The Cystic Fibrosis of Exocrine Pancreas","volume":"3","author":"Wilschanski","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ppul.24549","article-title":"Identification of CFTR variants in Latino patients with cystic fibrosis from the Dominican Republic and Puerto Rico","volume":"55","author":"Zeiger","year":"2020","journal-title":"Pediatr. Pulmonol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199502233320803","article-title":"The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group","volume":"332","author":"Neglia","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/17474124.2022.2084072","article-title":"Current clinical opinion on CFTR dysfunction and patient risk of pancreatitis: Diagnostic and therapeutic considerations","volume":"16","author":"Phadke","year":"2022","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/17460441.2021.1912732","article-title":"Discovery of CFTR modulators for the treatment of cystic fibrosis","volume":"16","author":"Pedemonte","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jcf.2016.05.007","article-title":"Cystic fibrosis in Latin America-Improving the awareness","volume":"15","author":"Castanos","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mgg3.337","article-title":"Spectrum of CFTR gene mutations in Ecuadorian cystic fibrosis patients: The second report of the p.H609R mutation","volume":"5","author":"Ortiz","year":"2017","journal-title":"Mol. Genet Genomic. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jcf.2006.07.004","article-title":"CFTR gene analysis in Latin American CF patients: Heterogeneous origin and distribution of mutations across the continent","volume":"6","author":"Perez","year":"2007","journal-title":"J. Cyst. Fibros."},{"key":"ref_29","first-page":"360","article-title":"Spectrum of CFTR mutations in Mexican cystic fibrosis patients: Identification of five novel mutations (W1098C, 846delT, P750L, 4160insGGGG and 297-1G-->A)","volume":"106","author":"Orozco","year":"2000","journal-title":"Hum. Genet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/jhg.2009.123","article-title":"CFTR allelic heterogeneity in Brazil: Historical and geographical perspectives and implications for screening and counseling for cystic fibrosis in this country","volume":"55","author":"Faucz","year":"2010","journal-title":"J. Hum. Genet"},{"key":"ref_31","first-page":"258","article-title":"A low prevalence of cystic fibrosis in Uruguayans of mainly European descent","volume":"3","author":"Cardoso","year":"2004","journal-title":"Genet Mol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/humu.9173","article-title":"CFTR mutations in patients from Colombia: Implications for local and regional molecular diagnosis programs","volume":"22","author":"Keyeux","year":"2003","journal-title":"Hum. Mutat."},{"key":"ref_33","first-page":"546","article-title":"CFTR allelic heterogeneity in Mexican patients with cystic fibrosis: Implications for molecular screening","volume":"62","author":"Yokoyama","year":"2010","journal-title":"Rev. Invest. Clin."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/(SICI)1096-8628(20000410)91:4<277::AID-AJMG7>3.0.CO;2-A","article-title":"CFTR mutations in three Latin American countries","volume":"91","author":"Restrepo","year":"2000","journal-title":"Am. J. Med. Genet"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/10\/2\/280\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:20:16Z","timestamp":1760120416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/10\/2\/280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["children10020280"],"URL":"https:\/\/doi.org\/10.3390\/children10020280","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}